Thyroid nodule laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 66: | Line 66: | ||
=== Molecular markers === | === Molecular markers === | ||
Thyroid specific molecular markers may be helpful in patients with intermediate cytology on FNA to decide on disease management: | Thyroid specific molecular markers may be helpful in patients with intermediate [[cytology]] on [[Needle aspiration biopsy|FNA]] to decide on disease management: | ||
* BRAF | * [[BRAF]] | ||
* RAS | * [[RAS]] | ||
* RET | * [[RET proto-oncogene|RET]] | ||
** Mostly seen in PTC | ** Mostly seen in [[papillary thyroid cancer]] (PTC) | ||
* Pax8-PPARg | * Pax8-PPARg | ||
* Galectin-3 | * [[Galectin]]-3 | ||
==References== | ==References== |
Revision as of 19:08, 25 October 2017
Thyroid nodule Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thyroid nodule laboratory findings On the Web |
American Roentgen Ray Society Images of Thyroid nodule laboratory findings |
Risk calculators and risk factors for Thyroid nodule laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory findings
Test | Indication | Finding |
---|---|---|
Serum thyrotropin |
|
|
Serum antithyroperoxidase level |
|
|
Free T4 |
| |
T3 |
|
|
Thyroglobulin |
|
|
Basal serum calcitonin |
|
|
Plasma metanephrine testing |
|
|
24-hour urinary collection
for catecholamines and metanephrines |
Molecular markers
Thyroid specific molecular markers may be helpful in patients with intermediate cytology on FNA to decide on disease management:
- BRAF
- RAS
- RET
- Mostly seen in papillary thyroid cancer (PTC)
- Pax8-PPARg
- Galectin-3